Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Helicobacter Pylori Eradication Therapy on the Healing of Iatrogenic Gastric Ulcer After Endoscopic Mucosal Resection of Gastric Neoplastic Lesions: a Multicenter, Randomized, Double Blind, and Placebo Controlled Trial

NCT00926809 is registered in ClinicalTrials.gov with Korean College of Helicobacter and Upper Gastrointestinal Research as lead sponsor.

NCT NCT00926809
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00926809 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Helicobacter Pylori Eradication Therapy on the Healing of Iatrogenic Gastric Ulcer After Endoscopic Mucosal Resection of Gastric Neoplastic Lesions: a Multicenter, Randomized, Double Blind, and Placebo Controlled Trial
Lead sponsor
Korean College of Helicobacter and Upper Gastrointestinal Research
Phase
Phase 4
Overall status
Unknown status
Start date
September 30, 2008
Completion date
December 31, 2010
Enrollment
232 (estimated)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

ulcer